Common Contracts

3 similar Secondary Block Trade Agreement contracts by Pfizer Inc

SECONDARY BLOCK TRADE AGREEMENT, made on 18 March 2025 BETWEEN
Secondary Block Trade Agreement • March 20th, 2025 • Pfizer Inc • Pharmaceutical preparations

Deutsche Bank AG, acting through its London Branch (which is trading for these purposes as Deutsche Numis) (“Deutsche Numis”);

SECONDARY BLOCK TRADE AGREEMENT, made on 14 January 2025 BETWEEN
Secondary Block Trade Agreement • January 16th, 2025 • Pfizer Inc • Pharmaceutical preparations

Loop Capital Markets LLC (“Loop Capital Markets”, and together with the Lead Managers, BofA, Deutsche Numis and GS, the “Managers”).

SECONDARY BLOCK TRADE AGREEMENT, made on 30 September 2024 BETWEEN
Secondary Block Trade Agreement • October 1st, 2024 • Pfizer Inc • Pharmaceutical preparations

Subject to the terms and conditions set out in this secondary block trade agreement (the “Agreement”), the Lead Managers agree, severally and not jointly or jointly and severally, to use their respective reasonable endeavours to procure purchasers for 540,000,000 (or such higher number as agreed between the Seller and the Lead Managers) ordinary shares with a nominal value of £0.01 per share in aggregate (the “Shares”) in Haleon plc (the “Company”) (the “Sale”) and the Managers excluding the Lead Managers agree, severally and not jointly or jointly and severally, to act as co-managers in connection with the Sale.